Authors: MUNROE WP KUNZ K DALMADYISRAEL C POTTER L SCHONFELD WH

Citation: Wp. Munroe et al., ECONOMIC-EVALUATION OF PHARMACIST INVOLVEMENT IN DISEASE MANAGEMENT IN A COMMUNITY PHARMACY SETTING, Clinical therapeutics, 19(1), 1997, pp. 113-123

Authors: GIDAL BE CRISMON ML WAGNER ML FAGAN SC PRIVITERA MD DALMADYISRAEL C GRAVES NM

Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .2. ADVANCES IN THE PHARMACOTHERAPYOF ALZHEIMER-DISEASE, PARKINSON DISEASE, AND STROKE, The Annals of pharmacotherapy, 30(12), 1996, pp. 1446-1451

Authors: GIDAL BE WAGNER ML PRIVITERA MD DALMADYISRAEL C CRISMON ML FAGAN SC GRAVES NM

Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .1. ADVANCES IN THE PHARMACOTHERAPYOF HEADACHE, EPILEPSY, AND MULTIPLE-SCLEROSIS, The Annals of pharmacotherapy, 30(11), 1996, pp. 1272-1276